Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Immuno-Oncology (I-O) Focus

Explore the latest updates and expert interviews

The Immuno-oncology (I-O) Focus on VJHemOnc is supported by Johnson & Johnson. This supporter has no influence over the production of the content.

Welcome to the Immuno-Oncology (I-O) Focus

Explore the latest updates in this field by hematological disease and therapy type. I-O Focus showcases expert interviews and discussions, podcasts and e-learning.

I-O is at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Agents including antibodies, immune checkpoint inhibitors, NK cells, vaccines and CAR-T cells are increasingly featured in treatment regimens, many of which are under testing in clinical trials currently. Although various questions remain open, it is essential that healthcare professionals understand these therapies, including recognizing and managing their toxicities, and when and how to use them.

Videos by Therapy Type

ADCs
Antibodies
Checkpoint Inhibitors
NK-Cell Therapy
Vaccines
Bispecific antibodies

Videos by Disease

Multiple Myeloma
CLL
Lymphoma
AML
ALL
MDS

Videos by congress

CAR-T Meeting 2024
ASH 2023
COSTEM 2023
iwCLL 2023
IMS 2023
SOHO 2023